9th ISMERAD | Alpha Therapy: New approaches in radionuclide therapy
The Symposium is intended for:
- Researchers and professionals active in the subfields of interest;
- European and Belgian health authorities and regulators;
- Radioisotope distributors and related transport companies
NH Gent Belfort
Hoogpoort 63
9000 Gent
Overview
The 9th Symposium on Medical Radioisotopes intends to:
• Provide information on the perspectives of the world production of medical radioisotopes during the years to come;
• Discuss challenges of the transport and distribution processes including safety, security, transparency and prompt delivery;
• Present breakthroughs in radiopharmacy and nuclear medicine;
• Introduce new industrial and research initiatives.
Topics
- Session 1: Origin/production of alpha-emitters. Challenges for the future - Overview of the activities
- Session 2: Logistics (waste management)
- Session 3: Studies | Clinical Potential | Dosimetry
- Session 4: The future
Programme
09:00 Registration and welcome coffee
09:30 Opening
- Welcome: Hans Van De Maele, PC Secretary
- Introduction: Bernard Ponsard, PC Chair
- Formal Opening: Ignace Lemahieu, RUG
09:45 Opening talk
- Lu-177 and the perspective of alpha therapy | Zéna Wimana, HUBruxelles
Session 1: Origin/production of alpha-emitters. Challenges for the future – Overview of the activities
- Ac-225 | Sven Van den Berghe, PanTera
- At-211 | Matthijs Sevenois, Molecular Imaging & THerapy research group (MITH)
- Pb-212 | Philippe Dasse, ARTBIO
11:00 Coffee break and poster session
11:30 Session 2: Logistics (waste management)
- Centralized radiopharmacies | Filip De Vos, Ghent University, Department of Radiopharmacy
- Waste Management | Pascal Froment, Be.Sure
- Drone Logistics – AEGLE project on drone logistics for radiopharmaceuticals | Hans Van De Maele, ORI Consult – AEGLE Drone Services
12:30 Poster session
- Poster competition
13:00 Lunch
14:00 NPO's | Short introduction
- ICPO
- Oncidium
- Rad4Med
14:30 Session 3: Studies / Clinical Potential / Dosimetry
- Clinical Potential | Mike Sathekge, University of Pretoria
- Challenges in Dosimetry | Michel Koole,KUL
15:15 Coffee break and poster session
15:45 Session 4: The future
- Potential of Terbium-161 | Florian Rosar, Nuclear Medicine Physician, Department of Nuclear Medicine, Saarland University
- PRISMAP: projects/preclinical studies REX on projects | Thomas Cocolios, KULeuven
16:30 Poster prize ceremony
- Traditionally 3 prizes are given for the best posters, respectively 500, 350 and 150 €
16:45 Closing
- Eric van Walle
16:50 Reception
Organisation
ISMERAD vzw
Preparation
Call for posters to the researchers in the field
Please submit the abstract(s) (20 to 30 lines, title and authors not included) for peer-review by mail to
bernard [dot] ponsard [at] sckcen [dot] be (bernard[dot]ponsard[at]sckcen[dot]be)
&
h [dot] vandemaele [at] be-wis [dot] com (h[dot]vandemaele[at]be-wis[dot]com)
Indicate clearly who is the principal investigator.
Deadline: March 31, 2024.
The abstracts of the accepted posters will be published. Similarly to the previous editions, this time too, three prizes (respectively 500, 350 and 150 €) will be allotted for the best three posters.
Learning outcomes
Click here for the Book of abstracts
Price
€200 - regular parcipants | € 175 Early Bird
€ 30 - students | € 25 Early Bird
